Andrew Mark Lew
8Patents
1h-index
13Co-inventors
44Inventor score
Filing activity: Nov 25, 1996 → Mar 21, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8349575B2 | Relay vaccine | Chemistry; Metallurgy | 5 | Active |
| US8426565B2 | Dendritic cell marker and uses thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US7423023B2 | Enhancement of immune response using targeting molecules | Chemistry; Metallurgy | 1 | Expired |
| US7423016B2 | Immune response targeting molecules | Chemistry; Metallurgy | 0 | Expired |
| US8097430B2 | Antigen targeting | Human Necessities | 0 | Expired |
| US7455984B2 | Immunoreactive and immunotherapeutic molecules | Emerging Cross-Sectional Technologies | 0 | Expired |
| US9988431B2 | Dendritic cell marker and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US6818217B1 | Immunoreactive peptides | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.